Obicetrapib Reduces HbA1c, New-Onset Diabetes Risk in ASCVD, HeFH
Obicetrapib and the Future of Lipid Management: A New Horizon for Cardiovascular Health The world of cardiovascular medicine is constantly evolving, and recent research on obicetrapib offers a compelling glimpse into the future of treating heart disease. This emerging therapy, a highly specific cholesteryl ester transfer protein (CETP) inhibitor, is showing promise in reducing LDL-C … Read more